Lawmakers in the House and Senate introduced legislation this week that could prohibit pharmaceutical companies from restricting access to 340B drug pricing discounts.
The Pharmaceutical Access to Invest in Essential, Needed Treatments & Support Act, introduced by Rep. Doris Matsui (D-Calif.) and Sen. Peter Welch (D-Vt.) would require drugmakers to provide 340B discounts to eligible hospitals that use contract pharmacies to dispense medications, according to a July 22 press release from 340B Health shared with Becker’s.
The bill would also ban drugmakers from placing conditions on those discounts and establish civil monetary penalties for violations, the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.